QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

23,110 signal articles · 325 in last 24h · 110,583 total before filter · latest 1h ago
325last 24h
2344last 7d
424● bullish (7d)
220● bearish (7d)
202publishers
AllMacro253Earnings1417M&A101Regulatory17Product16Analyst23
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Investing.com5d agoneutral
Atlassian rockets 23% after crushing earnings and flexing cloud & AI muscle

The company posted adjusted earnings per share of $1.87, beating the analyst consensus of $1.50 by $0.37. Revenue reached $1.77 billion, surpassing the $1.66 billion estimate and representing a 28% increase YoY from $1.38 billion in the same quarter last year. Cloud revenue grew 31% YoY to $1.21 billion, while Data Center revenue came in at $461.9 million, above the $414.6 million estimate.

U.S. Stocks Down on Hormuz Deal Doubts
The Wall Street Journal5d agoneutral
U.S. Stocks Down on Hormuz Deal Doubts

U.S. stocks fell in a jittery session amid doubts about the reopening of the Strait of Hormuz. The broad S&P 500 lost 13.59 points, or 0.18%, to 7709.96 and the tech-heavy Nasdaq Composite declined 15.09 points, or 0.06%, to 26348.35. U.S.-traded oil futures gained $2.07, or 2.8%, to $77.29 a barrel as trepidation about the Strait of Hormuz grew.

Navient (NASDAQ:NAVI) Delivers Impressive Q2 CY2026
StockStory5d agoneutral
Navient (NASDAQ:NAVI) Delivers Impressive Q2 CY2026

Student loan servicer Navient (NASDAQ:NAVI) beat Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 8.5% year on year to $150 million. Its GAAP profit of $0.26 per share was 25.3% above analysts’ consensus estimates.

Stocks Settle Lower as Middle East Tensions Rise
Barchart5d agoneutral
Stocks Settle Lower as Middle East Tensions Rise

The S&P 500 Index ($SPX ) (SPY ) closed down -0.18% on Thursday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.85%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.39%. September E-mini S&P futures (ESU26 ) fell -0.18%, and September E-mini Nasdaq futures...

Billionaire reveals how he made $15 billion using ChatGPT
TheStreet5d agoneutral
Billionaire reveals how he made $15 billion using ChatGPT

Michael Saylor, the billionaire founder and executive chairman of Strategy (Nasdaq: MSTR), has turned the former enterprise software company into the world’s largest corporate Bitcoin treasury. Strategy’s model involves raising money through common stock, debt and preferred shares, then using much ...

Microsoft (MSFT) vs. Alphabet (GOOGL): Which AI Giant Has the Edge in Next-Gen Cybersecurity?
Insider Monkey5d agoneutral
Microsoft (MSFT) vs. Alphabet (GOOGL): Which AI Giant Has the Edge in Next-Gen Cybersecurity?

Microsoft (NASDAQ:MSFT) just planted a flag in one of AI’s most consequential new battlegrounds. On Monday, the company introduced MAI-Cyber-1-Flash, its first cybersecurity-specific model, built into MDASH, the multi-agent system Microsoft already uses to hunt down and patch software vulnerabilities. Paired with GPT-5.4, the combination scored 96% on CyberGym, the industry’s leading vulnerability-detection benchmark, topping […]

Airbnb raises 2026 outlook after Q2 earnings top estimates
Proactive5d agoneutral
Airbnb raises 2026 outlook after Q2 earnings top estimates

Airbnb Inc (NASDAQ:ABNB, XETRA:6Z1) shares rose about 10% after Thursday’s closing bell after the alternative accommodation provider reported better-than-expected second quarter results and raised its full-year revenue and adjusted EBITDA margin guidance, citing continued strong travel...

Iovance Biotherapeutics (IOVA) Pops 43% on Stellar Q2. Here’s What Comes Next
Insider Monkey5d agoneutral
Iovance Biotherapeutics (IOVA) Pops 43% on Stellar Q2. Here’s What Comes Next

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) rocketed to a fresh 52-week high on Thursday, clocking as much as 47 percent gains, after management reported a 66 percent jump in revenues that signaled the strengthening demand for its treatment for advanced melanoma. In intra-day trading, the stock surged to its highest price of $6.39 before trimming gains to […]